The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
Market view
palonosetron · Injection, Solution
7 marketed package NDCs · 5 active manufacturers
Most dispensed: HYDROCHLORIDE .05 mg/mL · Injection, Solution · #1 vial, single-use/carton / 5 ml in 1 vial, single-use
Same drug class
Other molecules FDA puts in Serotonin-3 Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- fosnetupitant and palonosetron· 1 maker
- netupitant and palonosetron· 1 maker
- ondansetron tablets· 1 maker
- alosetron· 2 makers
- ondansetron hcl· 2 makers
- alosetron hydrochloride· 8 makers
- granisetron· 8 makers
- granisetron hydrochloride· 15 makers
- palonosetron hydrochloride· 26 makers
- ondansetron hydrochloride· 61 makers
- ondansetron· 63 makers
Common questions
- Is Palonosetron in shortage right now?
- No. FDA does not currently list Palonosetron in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Palonosetron?
- 5 companies have marketed Palonosetron in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.